Role of the NF-κB axis in immune modulation of osteoclasts and bone loss

Autoimmunity

Volumn 41, Issue 3, 2008, Pages 204-211

  Abu Amer, Yousef ^a   Darwech, Isra ^a   Otero, Jesse ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

IKK inflammation; NF kappa B; Osteoclast; Osteoimmunology

Indexed keywords

I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; OSTEOCLAST DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR ALPHA; CD40 LIGAND; LYMPHOTOXIN;

ALBERS SCHOENBERG DISEASE; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BONE DEVELOPMENT; BONE DISEASE; CELL DIFFERENTIATION; CELL SURVIVAL; CELL TYPE; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INHIBITION; GROWTH INHIBITION; HUMAN; IMMUNOMODULATION; INFLAMMATION; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PATHOPHYSIOLOGY; POLYARTHRITIS; PROTEIN TARGETING; SIGNAL TRANSDUCTION; ANIMAL; IMMUNOLOGY; OSTEITIS; REVIEW;

ANIMALS; BONE RESORPTION; CD40 LIGAND; HUMANS; LYMPHOTOXIN-ALPHA; NF-KAPPA B; OSTEITIS; OSTEOCLASTS; RANK LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 41449101904     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930701694543     Document Type: Article

References (62)

1. Goldring, SR (2002) Bone and joint destruction in rheumatoid arthritis: What is really happening?. J Rheumatol Suppl, 65, pp. 44-48.
2. Gravallese, EM (2002) Bone destruction in arthritis. Ann Rheum Dis, 61, p. 84ii.
3. Romas, E., Bakharevski, O., Hards, D., Kartsogiannis, V., Quinn, M., Ryan, P., Martin, T. and Gillespie, MT (2000) Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis. Arthritis Rheum, 43, pp. 821-826.
4. Takayanagi, H., Iizuka, H., Juji, T., Nakagawa, T., Yamamoto, A., Miyazaki, T., Koshihara, Y., Oda, H., Nakamura, K. and Tanaka, S. (2000) Involvement of receptor activator of nuclear factor kappaB ligand/ osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum, 43, pp. 259-269.
5. Teitelbaum, S. (2000) Bone resorption by osteoclasts. Science, 289, pp. 1504-1508.
6. Wong, BR, Besser, D., Kim, N., Arron, JR, Vologodskaia, M., Hanafusa, H. and Choi, Y. (1999) TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol Cell, 4, pp. 1041-1049.
7. Sato, K. and Takayanagi, H. (2006) Osteoclasts, rheumatoid arthritis and osteoimmunology. Curr Opin Rheumatol, 18, pp. 419-426.
8. Takayanagi, H. (2005) Mechanistic insight into osteoclast differentiation in osteoimmunology. J Mol Med, 83, pp. 170-179.
9. Takayanagi, H., Sato, K., Takaoka, A. and Taniguchi, T. (2005) Interplay between interferon and other cytokine systems in bone metabolism. Immunol Rev, 208, pp. 181-193.
10. Walsh, MC, Kim, N., Kadono, Y., Rho, J., Lee, SY, Lorenzo, J. and Choi, Y. (2006) Osteoimmunology: Interplay between the immune system and bone metabolism. Annu Rev Immunol, 24, pp. 33-63.
11. Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S. and Iwakura, Y. (2006) Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med, 203, pp. 2673-2682.
12. Abu-Amer, Y. and Tondravi, MM (1997) NFkB and bone: The breaking point. Nat Med, 3, pp. 1189-1190.
13. Baldwin Jr, AS (1996) The NF-kB and IkB proteins: New discoveries and insights. Annu Rev Immunol, 14, pp. 649-683.
14. Tak, P. and Firestein, G. (2001) NF-kB: A key role in inflammatory diseases. J Clin Invest, 107, pp. 7-11.
15. Iotsova, V., Caamano, J., Loy, J., Young, Y., Lewin, A. and Bravo, R. (1997) Osteopetrosis in mice lacking NFkB1 and NFkB2. Nat Med, 3, pp. 1285-1289.
16. Baldwin, A. (2001) The transcription factor NF-kB and human disease. J Clin Invest, 107, pp. 3-6.
17. Yamamoto, Y. and Gaynor, R. (2001) Therapeutic potential of inhibition of the NF-kB pathway in the treatment of inflammation and cancer. J Clin Invest, 107, pp. 135-142.
18. Boyce, B., Xing, L., Fransozo, G. and Siebenlist, U. (1999) Required and nonessential functions of nuclear factor-kB in bone cells. Bone, 25, pp. 137-139.
19. Siebenlist, U. and Franzoso, G. (2001) Structure, regulation and function of NF-kB. Proc Natl Acad Sci USA, 89, pp. 4333-4337.
20. Abu-Amer, Y. and Faccio, R. (2006) Therapeutic approaches in bone pathogeneses: Targeting the IKK/NF-κ B axis. Future Rheumatol, 1, pp. 133-146.
21. Ghosh, S. and Karin, M. (2002) Missing pieces in the NF-kB puzzle. Cell, 109, pp. S81-S96.
22. Karin, M., Yamamoto, Y. and Wang, M. (2004) The IKK NF-kB system: A treasure trove for drug development. Nat Rev, 3, pp. 17-26.
23. Franzoso, G., Carlson, L., Poljak, L., Shores, E., Brown, K., Leonardi, A., Tran, T., Boyce, B. and Siebenlist, U. (1997) Requirment for NF-kB in osteoclast and B-cell development. Genes Dev, 11, pp. 3482-3496.
24. Kollias, G., Douni, E., Kassiotis, G. and Kontoyiannis, D. (1999) On the role of TNF and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Immunol Rev, 169, pp. 175-194.
25. Jimi, E. and Ghosh, S. (2005) Role of nuclear factor-kappaB in the immune system and bone. Immunol Rev, 208, pp. 80-87.
26. Abu-Amer, Y. (2003) Mechanisms of inflammatory mediators in bone loss diseases. Molecular biology in orthopedics, pp. 229-239. AAOS, New York
27. Clohisy, J., Roy, B., Biondo, C., Frazier, E., Willis, D., Teitelbaum, S. and Abu-Amer, Y. (2003) Direct inhibition of NF-kB blocks bone erosion associated with inflammatory arthritis. J Immunol, 171, pp. 5547-5553.
28. Seetharaman, R., Mora, AL, Nabozny, G., Boothby, M. and Chen, J. (1999) Essential role of T cell NF-kB activation in collagen-induced arthritis. J Immunol, 163, pp. 1577-1583.
29. DiDonato, J., Hayakawa, M., Rothwarf, D., Zandi, E. and Karin, M. (1997) A cytokine-responsive I-kB kinase that activates the transcription factor Nf-kB. Nature, 388, pp. 548-554.
30. Mercurio, F., Zhu, H., Murray, B., Bennet, B., Li, J., Young, D., Barbosa, M. and Mann, M. (1997) IKK1 and IKK2: Cytokine-activated IkB kinases essential for NF-kB activation. Science, 278, pp. 866-872.
31. Regnier, C., Song, H., Gao, X., Goeddel, D., Cao, Z. and Rothe, M. (1997) Identification and characterization of an I-kB kinase. Cell, 90, pp. 373-383.
32. Stancovski, I. and Baltimore, D. (1997) NF-kB activation: The IkB kinase revealed?. Cell, 91, pp. 299-302.
33. Li, X., Massa, PE, Hanidu, A., Peet, GW, Aro, P., Savitt, A., Mische, S., Li, J. and Marcu, KB (2002) IKK-alpha, IKK-beta, and NEMO/IKK-gamma are each required for the NF-kB-mediated inflammatory response program. J Biol Chem, 277, pp. 45129-45140.
34. Li, XH, Fang, X. and Gaynor, RB (2001) Role of IKK-gamma/NEMO in assembly of the IkB kinase complex. J Biol Chem, 276, pp. 4494-4500.
35. Yamamoto, Y., Kim, DW, Kwak, YT, Prajapati, S., Verma, U. and Gaynor, RB (2001) IKKgamma/NEMO facilitates the recruitment of the Ikappa B proteins into the Ikappa B kinase complex. J Biol Chem, 276, pp. 36327-36336.
36. Rothwarf, D., Zandi, E., Natoli, G. and Karin, M. (1998) IKK-gamma is an essential regulatory subunit of the IkB kinase complex. Science, 395, pp. 297-300.
37. Makris, C., Roberts, JL and Karin, M. (2002) The carboxyl-terminal region of IkB kinase-gamma (IKK-g) is required for full IKK activation. Mol Cell Biol, 22, pp. 6573-6581.
38. May, MJ, Marienfeld, RB and Ghosh, S. (2002) Characterization of the Ikappa B-kinase NEMO binding domain. J Biol Chem, 277, pp. 45992-46000.
39. May, MJ, D'Acquisto, F., Madge, LA, Glockner, J., Pober, JS and Ghosh, S. (2000) Selective inhibition of NF-kappa B activation by a peptide that blocks the interaction of NEMO with the Ikappa B kinase complex. Science, 289, pp. 1550-1554.
40. Tak, P., Erlag, D., Upperele, K., Geest, Vd, Verbeek, M., Bennet, B., Boyle, D., Manning, A. and Firestein, G. (2001) Inhibitor of nuclear factor [Kappa]B Kinase [beta] is a key regulator of synovial inflammation. Arthritis Rheum, 44, pp. 1897-1907.
41. Dai, S., Hirayama, T., Abbas, S. and Abu-Amer, Y. (2004) The IkB Kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis. J Biol Chem, 279, pp. 37219-37222.
42. Jimi, E., Aoki, K., Saito, H., D'Acquisto, F., May, MJ, Nakamura, I., Sudo, T., Kojima, T., Okamoto, F. and Fukushima, H. (2004) Selective inhibition of NF-B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nat Med, 10, pp. 617-624.
43. Tanaka, M., Fuentes, ME, Yamaguchi, K., Durnin, MH, Dalrymple, SA, Hardy, KL and Goeddel, DV (1999) Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. Immunity, 10, pp. 421-429.
44. Kaisho, T., Takeda, K., Tsujimura, T., Kawai, T., Nomura, F., Terada, N. and Akira, S. (2001) IkB Kinase-alpha is essential for mature B cell development and function. J Exp Med, 193, pp. 417-426.
45. Ruocco, MG, Maeda, S., Park, JM, Lawrence, T., Hsu, L-C, Cao, Y., Schett, G., Wagner, EF and Karin, M. (2005) IkB kinase-beta, but not IKK-alpha, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss. J Exp Med, 201, pp. 1677-1687.
46. Andreakos, E. (2003) Targeting cytokines in autoimmunity: New approaches, new promise. Expert Opin Biol Ther, 3, pp. 435-447.
47. Izmailova, ES, Paz, N., Alencar, H., Chun, M., Schopf, L., Hepperle, M., Lane, JH, Harriman, G., Xu, Y. and Ocain, T. (2007) Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis. Arthritis Rheum, 56, pp. 117-128.
48. Senftleben, U., Cao, Y., Xiao, G., Greten, FR, Krahn, G., Bonizzi, G., Chen, Y., Hu, Y., Fong, A. and Sun, SC (2001) Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science, 293, pp. 1495-1499.
49. Chaisson, ML, Branstetter, DG, Derry, JM, Armstrong, AP, Tometsko, ME, Takeda, K., Akira, S. and Dougall, WC (2004) Osteoclast differentiation is impaired in the absence of IkB kinase-alpha. J Biol Chem, 279, pp. 54841-54848.
50. Aya, K., Alhawagri, M., Hagen-Stapleton, A., Kitaura, H., Kanagawa, O. and Novack, DV (2005) NF-(kappa)B-inducing kinase controls lymphocyte and osteoclast activities in inflammatory arthritis. J Clin Invest, 115, pp. 1848-1854.
51. Israel, A. (2003) A regulator branches out. Nature, 423, pp. 596-597.
52. van de Loo, FA and Berg, WB van den (2002) Gene therapy for rheumatoid arthritis. Lessons from animal models, including studies on interleukin-4, interleukin-10 and interleukin-1 receptor antagonist as potential disease modulators. Rheum Dis Clin North Am, 28, pp. 127-149.
53. Harjacek, M., Diaz-Cano, S., Alman, BA, Coburn, J., Ruthazer, R., Wolfe, H. and Steere, AC (2000) Prominent expression of mRNA for proinflammatory cytokines in synovium in patients with juvenile rheumatoid arthritis or chronic Lyme arthritis. J Rheumatol, 27, pp. 497-503.
54. Abu-Amer, Y. (2001) IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kB. J Clin Invest, 107, pp. 1375-1385.
55. Hirayama, T., Dai, S., Abbas, S., Yamanaka, Y. and Abu-Amer, Y. (2005) Inhibition of inflammatory bone erosion by constitutively active STAT-6 through blockade of JNK and NF-kB activation. Arthritis Rheum, 52, pp. 2719-2729.
56. Takayanagi, H., Ogazawara, K., Hida, S., Chiba, T., Murata, S., Sato, K., Oda, H., Tanaka, K. and Taniguichi, T. (2000) T-cell-mediated regulation of osteoclastogenesis by signaling cross-talk between RANKL and IFN-γ. Nature, 408, pp. 600-605.
57. Straus, DS, Pascual, G., Li, M., Welch, JS, Ricote, M., Hsiang, CH, Sengchanthalangsy, LL, Ghosh, G. and Glass, CK (2000) 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci USA, 97, pp. 4844-4849.
58. Mbalaviele, G., Abu-Amer, Y., Meng, A., Jaiswal, R., Beck, S., Pittenger, M., Thiede, M. and Marshak, S. (2000) Activation of peroxisome proliferator-activated receptor-y pathway inhibits osteoclast differentiation. J Biol Chem, 275, pp. 14388-14393.
59. Hoshino, K., Sugiyama, T., Matsumoto, M., Tanaka, T., Saito, M., Hemmi, H., Ohara, O., Akira, S. and Kaisho, T. (2006) IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. Nature, 440, pp. 949-953.
60. Li, Q., Lu, Q., Bottero, V., Estepa, G., Morrison, L., Mercurio, F. and Verma, IM (2005) Enhanced NF-kB activation and cellular function in macrophages lacking IkB kinase 1 (IKK1). Proc Natl Acad Sci USA, pp. 12425-12430.
61. Lawrence, T., Bebien, M., Liu, GY, Nizet, V. and Karin, M. (2005) IKK-alpha- limits macrophage NF-kB activation and contributes to the resolution of inflammation. Nature, 434, pp. 1138-1143.
62. Correa, RG, Matsui, T., Tergaonkar, V., Rodriguez-Esteban, C., Izpisua-Belmonte, JC and Verma, IM (2005) Zebrafish IkappaB kinase 1 negatively regulates NF-kappaB activity. Curr Biol, 15, pp. 1291-1295.